Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 11, Number 1—January 2005
Dispatch

Distribution and Characteristics of Escherichia coli Clonal Group A1

James R. Johnson*†Comments to Author , Andrew C. Murray*†, Michael A. Kuskowski*†, Sören Schubert‡, Marie-Francoise Prère§, Bertrand Picard¶, Raul Colodner#, Raul Raz#**, and TIARAInvestigators
Author affiliations: *VA Medical Center, Minneapolis, Minnesota, USA; †University of Minnesota, Minneapolis, Minnesota, USA; ‡Max von Pettenkofer-Institut für Hygiene und Medizinische Mikrobiologie, München, Germany; §Centre Hospitalier Universitaire Purpan, Toulouse, France; ¶Hôpital Morvan, Brest, France; #HaEmek Medical Center, Afula, Israel; **Technion School of Medicine, Afula, Israel

Main Article

Figure 1

XbaI pulsed-field gel electrophoresis profiles of Escherichia coli clonal group A (CGA) isolates and E. coli O157:H7. Lane numbers are shown below the gel image. Six CGA isolates from Chicago, IL (“A” series identifiers; lanes 1, 3, 4, 5, 7, and 8) exhibit similar profiles to reference CGA isolates SEQ102 (from California; lane 2) and UMN26 (from Minnesota; lane 6) (1). E. coli O157:H7 isolate G5244 (lane 9) exhibits a distinctive profile.

Figure 1. XbaI pulsed-field gel electrophoresis profiles of Escherichia coli clonal group A (CGA) isolates and E. coli O157:H7. Lane numbers are shown below the gel image. Six CGA isolates from Chicago, IL (“A” series identifiers; lanes 1, 3, 4, 5, 7, and 8) exhibit similar profiles to reference CGA isolates SEQ102 (from California; lane 2) and UMN26 (from Minnesota; lane 6) (1). E. coli O157:H7 isolate G5244 (lane 9) exhibits a distinctive profile.

Main Article

References
  1. Manges  AR, Johnson  JR, Foxman  B, O’Bryan  TT, Fullerton  KE, Riley  LW. Widespread distribution of urinary tract infections caused by a multidrug-resistant Escherichia coli clonal group. N Engl J Med. 2001;345:1007–13. DOIPubMedGoogle Scholar
  2. Johnson  JR, Manges  AR, O’Bryan  TT, Riley  LR. A disseminated multi-drug resistant clonal group of extraintestinal pathogenic Escherichia coli as a cause of pyelonephritis. Lancet. 2002;359:2249–51. DOIPubMedGoogle Scholar
  3. Manges  AR, Dietrich  PS, Riley  LW. Multidrug-resistant Escherichia coli clonal groups causing community-acquired pyelonephritis. Clin Infect Dis. 2004;38:329–34. DOIPubMedGoogle Scholar
  4. Stamm  WE. An epidemic of urinary tract infections? N Engl J Med. 2001;345:1055–7. DOIPubMedGoogle Scholar
  5. Petrof  EO, Schwartz  DN, Quinnn  JP. Urinary tract infections and a multidrug-resistant Escherichia coli clonal group [letter]. N Engl J Med. 2002;346:535. DOIPubMedGoogle Scholar
  6. Burman  WJ, Breese  PE, Murray  BE, Singh  KV, Batal  HA, MacKenzie  TA, Conventional and molecular epidemiology of trimethoprim-sulfamethoxazole resistance among urinary Escherichia coli isolates. Am J Med. 2003;115:358–64. DOIPubMedGoogle Scholar
  7. Enne  VI, Livermore  DM, Stephens  P, Hall  LCM. Persistence of sulphonamide resistance in Escherichia coli in the UK despite national prescribing restriction. Lancet. 2001;357:1325–8. DOIPubMedGoogle Scholar
  8. Clermont  O, Bonacorsi  S, Bingen  E. Rapid and simple determination of the Escherichia coli phylogenetic group. Appl Environ Microbiol. 2000;66:4555–8. DOIPubMedGoogle Scholar
  9. Johnson  JR, Kuskowski  M, Denamur  E, Elion  J, Picard  B. Clonal origin, virulence factors, and virulence [letter and reply]. Infect Immun. 2000;68:424–5. DOIPubMedGoogle Scholar
  10. Johnson  JR, Murray  AC, Gajewski  A, Sullivan  M, Shippes  P, Kuskowski  MA, Isolation and molecular characterization of nalidixic acid-resistant extraintestinal pathogenic Escherichia coli from retail chicken products. Antimicrob Agents Chemother. 2003;47:2161–8. DOIPubMedGoogle Scholar
  11. National Committee for Clinical Laboratory Standards. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically, 6th ed. Vol. 23, no. 2. M7-A6. Wayne (PA): The Committee; 2003.
  12. National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial susceptibility testing; fourteenth informational supplement. Vol. 24, no. 1. M100-S14. Wayne (PA): The Committee; 2004.
  13. Johnson  JR, Kuskowski  MA, Owens  K, Gajewski  A, Winokur  PL. Phylogenetic origin and virulence genotype in relation to resistance to fluoroquinolones and/or extended spectrum cephalosporins and cephamycins among Escherichia coli isolates from animals and humans. J Infect Dis. 2003;188:759–68. DOIPubMedGoogle Scholar
  14. Johnson  JR, Russo  TA. “Uropathogenic” Escherichia coli as agents of diverse non-urinary-tract extraintestinal infections. J Infect Dis. 2002;186:859–64. DOIPubMedGoogle Scholar
  15. Johnson  JR. Owens, Manges A, Riley L. Rapid and specific detection of Escherichia coli clonal group A by gene-specific PCR. J Clin Microbiol. 2004;42:2618–22. DOIPubMedGoogle Scholar

Main Article

1Presented at the American Society for Microbiology 103rd General Meeting, May 18–22, 2003, Washington, D.C.

2The TIARA investigators include the following: Sacared Bodison (University of Maryland, College Park, MD), Franklin R. Cockerill, III (Mayo Clinic and Mayo Medical School, Rochester, MN), Clovis Arns da Cunha (Curitiba-PR, Brazil), Peter Echeverria and Sriluck Simasathien (Armed Forces Research Institute of Medical Sciences and Phramonkutkho Army Hospital, Bangkok, Thailand), Wim Gaastra (University of Utrecht, Utrecht, The Netherlands), Lucinda M.C. Hall (St Bartholomew's and the Royal London School of Medicine and Dentistry, London, UK), Marina Klein (McGill University Health Centre, Montreal, Quebec, Canada), Hank A. Lockman (Battelle Memorial Institute, Columbus, OH), Imad Omer and Jane R. Schwebke (University of Alabama, Birmingham, AL), Guillem Prats (Hospital Vall d'Hebron, Barcelona, Spain), Robert M. Rakita (Virginia Mason Medical Center, Seattle, WA), Susan Rossman (Texas Childrens Hospital, Houston, TX), Ronald Schiffman (Southern Arizona VA Medical Center, Tucson, AZ), Ronald Smith (Billings Clinic and Providence Medical Center, Billings, MT), and Patricia L. Winokur (VA Medical Center and University of Iowa, Iowa City, IA).

Page created: April 14, 2011
Page updated: April 14, 2011
Page reviewed: April 14, 2011
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external